LXRX
Lexicon Pharmaceuticals, Inc.Company with tickers: LXRX
Market Cap
$986.12M
Shares Outstanding
444,196,390
CIK
1062822
CUSIP
528872302
13F Activity (30d)
4 filings
2 filers
Website
Visit website
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-03 | Sullivan Diane E. |
Director | Convert | 89,312 |
| 2026-06-03 | Cheung Ivan |
Director | Convert | 89,312 |
| 2026-06-03 | Sullivan Diane E. |
Director | Convert | 89,312 |
| 2026-06-03 | SOBECKI CHRISTOPHER J |
Director | Convert | 89,312 |
| 2026-06-03 | Swain Judith L |
Director | Convert | 89,312 |
| 2026-06-03 | Swain Judith L |
Director | Convert | 89,312 |
| 2026-06-03 | BARKER SAM L |
Director | Convert | 89,312 |
| 2026-06-03 | Cheung Ivan |
Director | Convert | 89,312 |
| 2026-06-03 | DEBBANE RAYMOND |
Director | Convert | 89,312 |
| 2026-06-03 | BARKER SAM L |
Director | Convert | 89,312 |
| 2026-06-03 | Amouyal Philippe |
Director | Convert | 89,312 |
| 2026-06-03 | SOBECKI CHRISTOPHER J |
Director | Convert | 89,312 |
| 2026-06-03 | DEBBANE RAYMOND |
Director | Convert | 89,312 |
| 2026-06-03 | Amouyal Philippe |
Director | Convert | 89,312 |
| 2026-05-01 | Sullivan Diane E. |
Director | Award | 43,478 |
| 2026-05-01 | Cheung Ivan |
Director | Award | 35,714 |
| 2026-05-01 | BARKER SAM L |
Director | Award | 35,714 |
| 2026-05-01 | SOBECKI CHRISTOPHER J |
Director | Award | 43,478 |
| 2026-05-01 | Swain Judith L |
Director | Award | 43,478 |
| 2026-05-01 | Sullivan Diane E. |
Director | Award | 35,714 |
| 2026-05-01 | Amouyal Philippe |
Director | Award | 43,478 |
| 2026-05-01 | Cheung Ivan |
Director | Award | 43,478 |
| 2026-05-01 | DEBBANE RAYMOND |
Director | Award | 43,478 |
| 2026-05-01 | BARKER SAM L |
Director | Award | 43,478 |
| 2026-05-01 | Amouyal Philippe |
Director | Award | 35,714 |
| 2026-05-01 | Swain Judith L |
Director | Award | 35,714 |
| 2026-05-01 | SOBECKI CHRISTOPHER J |
Director | Award | 35,714 |
| 2026-05-01 | DEBBANE RAYMOND |
Director | Award | 35,714 |
| 2026-04-30 | Artal Participations S.a r.l. |
Director, 10% Owner | Award | 408,434 |
| 2026-04-30 | Artal Participations S.a r.l. |
Director, 10% Owner | Convert | 20,421,735 |
| 2026-04-30 | Artal Participations S.a r.l. |
Director, 10% Owner | Convert | 408,434 |
| 2026-02-28 | Martens Rachel Yap |
SVP, Partnerships & Corp Strat | Convert | 67,090 |
| 2026-02-28 | McDermott Wendy |
SVP, Human Resources | Convert | 144,393 |
| 2026-02-28 | DeFrancesco Lisa |
SVP, IR and Corp Comm | Convert | 128,190 |
| 2026-02-28 | Gopinathan Suma |
SVP, Discovery | Tax | 24,338 |
| 2026-02-28 | McDermott Wendy |
SVP, Human Resources | Tax | 68,107 |
| 2026-02-28 | Crum Brian T |
SVP, General Counsel & Secr. | Convert | 69,386 |
| 2026-02-28 | Granowitz Craig B |
SVP, Chief Medical Officer | Convert | 74,226 |
| 2026-02-28 | Gopinathan Suma |
SVP, Discovery | Convert | 20,310 |
| 2026-02-28 | DeFrancesco Lisa |
SVP, IR and Corp Comm | Convert | 24,674 |
| 2026-02-28 | McDermott Wendy |
SVP, Human Resources | Convert | 27,697 |
| 2026-02-28 | Granowitz Craig B |
SVP, Chief Medical Officer | Convert | 74,226 |
| 2026-02-28 | Coiante Scott M |
SVP, Chief Financial Officer | Tax | 54,881 |
| 2026-02-28 | Granowitz Craig B |
SVP, Chief Medical Officer | Convert | 35,790 |
| 2026-02-28 | Exton Michael |
Director, Chief Executive Officer | Tax | 204,831 |
| 2026-02-28 | Exton Michael |
Director, Chief Executive Officer | Convert | 503,263 |
| 2026-02-28 | Granowitz Craig B |
SVP, Chief Medical Officer | Convert | 35,790 |
| 2026-02-28 | DeFrancesco Lisa |
SVP, IR and Corp Comm | Convert | 24,674 |
| 2026-02-28 | Crum Brian T |
SVP, General Counsel & Secr. | Tax | 105,019 |
| 2026-02-28 | McDermott Wendy |
SVP, Human Resources | Convert | 27,697 |
Showing 1–50 of 760 transactions